Matrix-Bio Options Metabolite Biomarker Technology From Purdue University to Evaluate Opportunities for New Cancer Diagnostic Tests

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FORT WAYNE, Ind.--(BUSINESS WIRE)--Matrix-Bio Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive agreement with the Purdue Research Foundation optioning metabolite biomarker technology and eight patent applications to evaluate the commercial potential of cancer diagnostics tests based on the technologies.

Help employers find you! Check out all the jobs and post your resume.

Back to news